Ardena Contract Manufacturing & Development (CDMO) Profile
Ardena is a fully integrated CDMO with a core focus on bringing molecules to the clinics.
Our full-service offering covers:
• Drug Substance: Navigating your small-molecule API project through route scouting, development and manufacturing under accelerated timelines.
• Solid State Research: Our High Throughput Screening methodology for salt, co-crystal, polymorph, and amorphous form screening speeds up the selection of a solid form qualifying for development.
• Drug Product: Our expertise includes phase-appropriate development and manufacturing under cGMP conditions, as well as clinical packaging and logistics. We count with bioavailability enhancement technologies and expertise, such as spray drying.
• Nanomedicines: As a leading CDMO for nanomedicines, we provide scalable formulation, process, and analytical development as well as GMP manufacturing, enabling our customers to reach their clinical schedules in time.
• CMC Regulatory Services: With in-depth understanding of scientific writing, CMC documentation requirements, and regulatory processes, Ardena fast-tracks your product towards global approval.
• Bioanalysis: We offer solutions for all types of drug products and biomarkers, from small molecules to proteins including antibodies, ADCs, oligonucleotides and vaccines.
CDMO Services:
API and/or Ingredients; Finished Dosage Forms (Small Molecule Drugs) Liquids; Semi-solids; Solids; Sterile Vials Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development
Year Founded: 2017
Head Office: Mariakerke, Belgium
Number of Facilities: 45415
Facility locations: Europe
Website: Visit the Ardena website
Linkedin: Connect on Linkedin